TRIVARX LIMITED |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.026 AUD | 0.00% |
|
+8.33% | -13.33% |
| Feb. 28 | TrivarX Limited Reports Earnings Results for the Half Year Ended December 31, 2023 | CI |
| Feb. 09 | TrivarX Signs Collaboration with Northern Michigan University on Sleep Research | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration
TrivarX Limited, formerly Medibio Limited, is an Australia-based mental health technology company engaged in the use of objective measures to aid in the early detection and screening of mental health conditions. Through the Companyâs corporate health product, it offers mental well-being solutions for businesses and is also developing products to serve the healthcare provider market. The principal activity of the Company is conducting clinical research, product development and early-stage commercialization of a mental health technology using objective biomarkers to assist in the screening, diagnosing, monitoring, and management of depression and other mental health conditions. It has launched its consumer mobile application to help measure, monitor, and manage stress, called LUCA. LUCA is a biometric assessment tool that measures sleep stress, activity stress, and cardiac stress that allows consumers to monitor their daily stress levels through their own personal wearable device.
Sector
Pharmaceuticals
Chiffre d''affaires - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -13.33% | 5.74M | |
| +5.31% | 70.44B | |
| +10.97% | 8.94B | |
| -16.83% | 4.75B | |
| +43.48% | 4.5B | |
| +3.20% | 3.85B | |
| -21.36% | 2.34B | |
| -29.67% | 2.2B | |
| +8.38% | 1.96B | |
| +3.90% | 1.65B |
- Stock Market
- Equities
- TRI Stock
- News TrivarX Limited
- Medibio Adds Executive Director Role to CEO, Changes Principal Pace of Business
